Metocor

Metoprolol Tartrate, the active ingredient in Metocor, is a beta blocker presented as an oral tablet for systemic use. It lowers blood pressure, relieves angina, and helps manage heart rhythm disorders and post‑myocardial infarction care in adult patients. It is commonly prescribed for patients requiring cardiovascular risk reduction.

GNH USA supplies Metocor as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with adherence to quality standards, regulatory requirements and reliable logistics for global distribution.

Metocor (metoprolol tartrate) is a selective β1‑adrenergic blocker used in cardiovascular disease management.

Hypertension: reduces systolic and diastolic blood pressure, decreasing cardiovascular strain. Angina pectoris: decreases myocardial oxygen demand, relieving chest‑pain episodes. Myocardial infarction: improves survival by lowering cardiac workload and preventing recurrent ischemic events. Heart failure: lowers heart rate and improves ventricular filling, aiding symptom control.

Metocor may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Sleep disturbances or vivid dreams

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in patients with reactive airway disease - Acute heart failure exacerbation - Allergic reactions (rash, angioedema, anaphylaxis) - Depression or mood changes

Before initiating Metocor, clinicians should consider several safety measures.

Monitor blood pressure and heart rate regularly: adjust dose if values fall outside therapeutic range. Assess renal and hepatic function: dose reduction may be needed in impairment. Caution in patients with asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchoconstriction. Avoid abrupt discontinuation: taper dose to prevent rebound tachycardia or hypertension. Use with caution in diabetic patients: may mask hypoglycaemia symptoms. Store at room temperature: keep in the original pack, protect from moisture.

Metocor can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: additive negative‑chronotropic effect may cause severe bradycardia. - Amiodarone: increases plasma metoprolol levels, raising risk of hypotension. - Clonidine withdrawal: abrupt cessation while on metoprolol can precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely): - Calcium‑channel blockers (non‑dihydropyridine): may require dose adjustment. - NSAIDs: can blunt antihypertensive response. - Antidiabetic agents (insulin, sulfonylureas): monitor glucose as beta‑blockade may mask hypoglycaemia. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise metoprolol concentrations.